Compounds > 3,4-dihydroxyphenylacetaldehyde
Page last updated: 2024-09-03

3,4-dihydroxyphenylacetaldehyde and cyclosporine

3,4-dihydroxyphenylacetaldehyde has been researched along with cyclosporine in 1 studies

Compound Research Comparison

Studies
(3,4-dihydroxyphenylacetaldehyde)		Trials
(3,4-dihydroxyphenylacetaldehyde)		Recent Studies (post-2010)
(3,4-dihydroxyphenylacetaldehyde)		Studies
(cyclosporine)		Trials
(cyclosporine)		Recent Studies (post-2010) (cyclosporine)
9905030,5473,8026,558

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, AM; Burke, WJ; Conway, AD; Jain, JC; Kristal, BS; Li, SW; Ulluci, PA1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and cyclosporine

ArticleYear
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria.
    Free radical biology & medicine, 2001, Apr-15, Volume: 30, Issue:8

    Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Aminobenzoic Acid; Aminobenzoates; Animals; Aristolochic Acids; Cell Death; Cell Differentiation; Cyclosporine; Dopamine; Dopamine Antagonists; Enzyme Inhibitors; Ion Channels; Male; Membrane Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nerve Growth Factor; para-Aminobenzoates; Parkinson Disease; PC12 Cells; Phenanthrenes; Rats; Rats, Inbred F344; Respiration; Rotenone; Trifluoperazine; Uncoupling Agents

2001